[PETGAS] YoY Annualized Quarter Result on 31-Dec-2015 [#4]

Announcement Date
24-Feb-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Dec-2015 [#4]
Profit Trend
QoQ- -5.24%
YoY- 7.83%
View:
Show?
Annualized Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 5,498,074 4,809,623 4,561,280 4,455,955 4,391,716 3,892,139 3,576,771 7.42%
PBT 2,351,896 2,252,713 2,106,769 2,002,110 2,354,459 1,896,419 1,851,286 4.06%
Tax -443,715 -435,780 -370,468 -16,240 -512,379 182,457 -446,409 -0.10%
NP 1,908,181 1,816,933 1,736,301 1,985,870 1,842,080 2,078,876 1,404,877 5.23%
-
NP to SH 1,810,259 1,792,682 1,739,052 1,987,452 1,843,186 2,078,888 1,405,049 4.31%
-
Tax Rate 18.87% 19.34% 17.58% 0.81% 21.76% -9.62% 24.11% -
Total Cost 3,589,893 2,992,690 2,824,979 2,470,085 2,549,636 1,813,263 2,171,894 8.73%
-
Net Worth 12,971,775 12,515,084 11,966,777 11,438,851 10,533,780 10,265,662 9,167,465 5.95%
Dividend
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Div 1,424,687 1,305,963 1,226,813 1,187,239 1,088,302 1,088,302 989,366 6.26%
Div Payout % 78.70% 72.85% 70.54% 59.74% 59.04% 52.35% 70.42% -
Equity
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Net Worth 12,971,775 12,515,084 11,966,777 11,438,851 10,533,780 10,265,662 9,167,465 5.95%
NOSH 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 0.00%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 34.71% 37.78% 38.07% 44.57% 41.94% 53.41% 39.28% -
ROE 13.96% 14.32% 14.53% 17.37% 17.50% 20.25% 15.33% -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 277.86 243.07 230.52 225.19 221.95 196.70 180.76 7.42%
EPS 91.49 90.60 87.89 100.44 93.15 105.06 71.01 4.31%
DPS 72.00 66.00 62.00 60.00 55.00 55.00 50.00 6.26%
NAPS 6.5556 6.3248 6.0477 5.7809 5.3235 5.188 4.633 5.95%
Adjusted Per Share Value based on latest NOSH - 1,978,732
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 277.87 243.08 230.52 225.20 221.96 196.71 180.77 7.42%
EPS 91.49 90.60 87.89 100.44 93.15 105.07 71.01 4.31%
DPS 72.00 66.00 62.00 60.00 55.00 55.00 50.00 6.26%
NAPS 6.5559 6.3251 6.048 5.7811 5.3237 5.1882 4.6332 5.95%
Price Multiplier on Financial Quarter End Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 -
Price 19.20 17.48 21.30 22.70 22.16 24.28 19.52 -
P/RPS 6.91 7.19 9.24 10.08 9.98 12.34 10.80 -7.16%
P/EPS 20.99 19.29 24.24 22.60 23.79 23.11 27.49 -4.39%
EY 4.76 5.18 4.13 4.42 4.20 4.33 3.64 4.57%
DY 3.75 3.78 2.91 2.64 2.48 2.27 2.56 6.56%
P/NAPS 2.93 2.76 3.52 3.93 4.16 4.68 4.21 -5.85%
Price Multiplier on Announcement Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 18/02/19 26/02/18 23/02/17 24/02/16 17/02/15 10/02/14 21/02/13 -
Price 18.12 17.66 20.58 22.40 22.38 23.10 18.22 -
P/RPS 6.52 7.27 8.93 9.95 10.08 11.74 10.08 -7.00%
P/EPS 19.81 19.49 23.42 22.30 24.03 21.99 25.66 -4.21%
EY 5.05 5.13 4.27 4.48 4.16 4.55 3.90 4.39%
DY 3.97 3.74 3.01 2.68 2.46 2.38 2.74 6.37%
P/NAPS 2.76 2.79 3.40 3.87 4.20 4.45 3.93 -5.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment